NCT00823459 - Everolimus in Treating Patients With Recurrent Low-Grade Glioma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 23, 2009

Primary Completion Date

June 12, 2017

Study Completion Date

November 13, 2017

Conditions

Adult Diffuse AstrocytomaAdult Mixed GliomaAdult OligodendrogliomaAdult Subependymal Giant Cell AstrocytomaRecurrent Adult Brain Neoplasm

Interventions

DRUG

Everolimus

Given PO

OTHER

Archival Tissue Analysis

Correlative studies

Trial Locations (1)

University of California, San Francisco, San Francisco